secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moleculin Biotech, Inc. (MBRX)
CIK:        0001659617
Form:       8-K
Filed at:   2026-04-15T23:59:59+00:00
Accession:  0001437749-26-012325
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve issuance of up to 6.4M warrant shares; name change rejected
--------------------------------------------------------------------------------

- Shareholders approved issuance of up to 6,367,956 shares upon exercise of warrants issued Feb 20, 2026.
- Name change to Moleculin Inc. failed; received 2,015,174 'For' votes but needed majority of 4,933,110 outstanding shares.
- Adjournment proposal passed to allow further proxy solicitation if needed.
- A total of 2,382,989 shares were present at the Special Meeting, constituting a quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659617/000143774926012325/0001437749-26-012325-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659617/000143774926012325/mbrx20260408_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-012325

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer